Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Settlements Stir Supreme Court Interest During Slow Term For Pharma Cases

This article was originally published in The Tan Sheet

Executive Summary

High court seeks Solicitor General's view on whether patent settlements blocking authorized generics are anticompetitive; court denies GSK petition challenging payer claims in Avandia litigation.

Advertisement

Related Content

FTC Focus On Pay-For-Delay Deals Continues; Endo Agrees To 10-Year Abstention
Do Payers Pay More If Drug Risks Are Not Disclosed? GSK Seeks Supreme Court Answer
PhRMA Fears 'Potentially Limitless' State Suits After Risperdal Case
J&J Petitions Supreme Court On Pre-emption, ‘Clear Evidence’ In OTC Litigation

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS108392

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel